Rector Laser Technology, LLC is the exclusive U.S. Distributor for the most cutting edge low-level l
06/28/2016
Rector Laser Technology, LLC is the exclusive US distributor for the most cutting edge low-level laser therapy (LLLT). Our laser devices have proven effective in treating many different medical conditions such as diabetes, inflammation, acute wounds and fracturies, chronic pain, high blood pressure, arthritis, and other cardiovascular and cerebrovascular diseases. Our products are currently in 50 other countries and have achieved ISO 9001 and ISO 13485 Certifications. In addition, our lasers have been CE and ROHS approved. We also offer a variety of other LLLT medical lasers treating hair loss, nail fungus, acne and skin wrinkles.
Be the first to know and let us send you an email when Rector Laser Technology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Rector Laser Technology, LLC fuses the highest quality in medical lasers globally with Eastern medicine. We are the exclusive U.S. distributor of these low level laser therapy devices (LLLT). This technology has proven effective in treating various medical conditions such as diabetes, inflammation, acute wounds and fractures, chronic pain, high blood pressure, arthritis, asthma, and other cardiovascular and cerebral vascular diseases. Our products are in 50 other countries and have achieved ISO 9001 and ISO 13485 Certifications. In addition, Rector Lasers have been CE and ROHS approved.
What is low level laser therapy?
Low level laser therapy is the application of red or near infrared light to stimulate and begin a series of biochemical changes to repair damaged cells and accelerate the body's natural healing process. The use of laser or LED light therapy improves tissue repair (skin wounds, muscle, tendon, bone, nerves), reduces inflammation and reduces pain wherever the beam is applied. After purchasing the device, treatments can be done at home and typically takes 10 - 30 minutes depending on the condition.
How it works?
LLLT works predominately on a protein in the mitochondria (cytochrome c oxidase) to increase ATP and reduce oxidative stress. A cascade of mitochondrial and intracellular downstream effects lead to improved tissue repair and reduced inflammation.
Low level laser technology was discovered 40 years ago and has continued to be studied. Current studies on LLLT, also called photobiomodulation, are taking place at Harvard University, Stanford, Boston University, MIT, University of Texas, and University of Toronto.This technology has been tested in over 400 clinical trials (RCT's) with thousands of laboratory studies and publishings in many leading journals including The Lancet, BMJ, Nature, PNAS, Spine, Muscle and Nerve, Pain, Stroke etc.
